{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "1bebde83",
   "metadata": {},
   "source": [
    "# Exploratory Analysis â€” Clinical Trials CSV\n",
    "\n",
    "This notebook performs an initial exploration of `../raw/clin_trials.csv` to understand the data structure, missing values, and identify potential categorical columns.\n",
    "```"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "7a3d98eb",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "\n",
    "df = pd.read_csv('../raw/clin_trials.csv')"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7d5e8cbf",
   "metadata": {},
   "source": [
    "# Basic Exploration\n",
    "\n",
    "Check the shape and column data types to understand the dataset size and structure.\n",
    "```"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "id": "3425c330",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "____________________________________________________________\n",
      "Shape: (496615, 17)\n",
      "\n",
      "Data types:\n",
      "Unnamed: 0                   int64\n",
      "Organization Full Name      object\n",
      "Organization Class          object\n",
      "Responsible Party           object\n",
      "Brief Title                 object\n",
      "Full Title                  object\n",
      "Overall Status              object\n",
      "Start Date                  object\n",
      "Standard Age                object\n",
      "Conditions                  object\n",
      "Primary Purpose             object\n",
      "Interventions               object\n",
      "Intervention Description    object\n",
      "Study Type                  object\n",
      "Phases                      object\n",
      "Outcome Measure             object\n",
      "Medical Subject Headings    object\n",
      "dtype: object\n"
     ]
    }
   ],
   "source": [
    "print(\"_\" * 60)\n",
    "print(f\"Shape: {df.shape}\")\n",
    "print(f\"\\nData types:\")\n",
    "print(df.dtypes)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7a2a5ca6",
   "metadata": {},
   "source": [
    "## Missing Values Analysis\n",
    "\n",
    "Compute missing value counts and percentages for each column. Only columns with missing values are displayed.\n",
    "```"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "id": "20efa61d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "____________________________________________________________\n",
      "Missing values\n",
      "              missing_count  missing_percent\n",
      "Phases               183844        37.019421\n",
      "Standard Age            885         0.178206\n"
     ]
    }
   ],
   "source": [
    "print(\"_\" * 60)\n",
    "print(\"Missing values\")\n",
    "missing = df.isnull().sum()\n",
    "missing_percent = (missing / len(df)) * 100\n",
    "missing_df = pd.DataFrame({\n",
    "    'missing_count': missing, \n",
    "    'missing_percent': missing_percent\n",
    "})\n",
    "print(missing_df[missing_df['missing_count'] > 0].sort_values(by='missing_percent', ascending=False))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a123473a",
   "metadata": {},
   "source": [
    "## Sample Data Preview\n",
    "\n",
    "Display the first few rows to inspect actual data values.\n",
    "```"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "id": "108cdea5",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "____________________________________________________________\n",
      "Sample data\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>Organization Full Name</th>\n",
       "      <th>Organization Class</th>\n",
       "      <th>Responsible Party</th>\n",
       "      <th>Brief Title</th>\n",
       "      <th>Full Title</th>\n",
       "      <th>Overall Status</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Standard Age</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Primary Purpose</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Intervention Description</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Outcome Measure</th>\n",
       "      <th>Medical Subject Headings</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>Montefiore Medical Center</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>SPONSOR</td>\n",
       "      <td>Kinesiotape for Edema After Bilateral Total Kn...</td>\n",
       "      <td>Effect of Kinesiotaping on Edema Management, P...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>2021-10-18</td>\n",
       "      <td>ADULT OLDER_ADULT</td>\n",
       "      <td>Arthroplasty Complications, Arthroplasty, Repl...</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>Kinesio(R)Tape for edema control</td>\n",
       "      <td>Kinesio(R)Tape is an elastic, cotton tape with...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Change from baseline and during 1-2-day time i...</td>\n",
       "      <td>Edema</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>Seoul National University Hospital</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>An Open-labeled Trial of Ramipril in Patients ...</td>\n",
       "      <td>An Open-labeled Trial of Ramipril in Patients ...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>2004-10</td>\n",
       "      <td>ADULT OLDER_ADULT</td>\n",
       "      <td>Migraine With Hypertension</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>Ramipril</td>\n",
       "      <td>ramipril 2.5mg twice a day</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>headache frequency</td>\n",
       "      <td>Migraine Disorders Hypertension</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>Federico II University</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>PRINCIPAL_INVESTIGATOR</td>\n",
       "      <td>OCTA in Epivascular Glia After Dex Implant</td>\n",
       "      <td>Evaluation of Changes in Epivascular Glia Befo...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>2021-01-01</td>\n",
       "      <td>ADULT OLDER_ADULT</td>\n",
       "      <td>Diabetic Retinopathy</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>Dexamethasone intravitreal implant</td>\n",
       "      <td>Dexamethasone intravitreal implant</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>Changes in epivascular glia after Dexamethason...</td>\n",
       "      <td>Diabetic Retinopathy</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>Sidney Kimmel Comprehensive Cancer Center at J...</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>SPONSOR</td>\n",
       "      <td>Preoperative Immune Checkpoint Inhibitor for P...</td>\n",
       "      <td>Preoperative Immune Checkpoint Inhibitor Thera...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>2019-07-08</td>\n",
       "      <td>ADULT OLDER_ADULT</td>\n",
       "      <td>Head and Neck Squamous Cell Carcinoma, Head an...</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>Nivolumab 480mg and surgical resection</td>\n",
       "      <td>One dose of Nivolumab 480mg given four weeks p...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>Safety as measured by number of participants w...</td>\n",
       "      <td>Carcinoma Carcinoma, Squamous Cell Head and Ne...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>4</td>\n",
       "      <td>Northwestern University</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>SPONSOR</td>\n",
       "      <td>Genistein in Treating Patients With Prostate C...</td>\n",
       "      <td>Phase 2 Trial of Genistein in Men With Circula...</td>\n",
       "      <td>TERMINATED</td>\n",
       "      <td>2011-02-03</td>\n",
       "      <td>ADULT OLDER_ADULT</td>\n",
       "      <td>Adenocarcinoma of the Prostate, Recurrent Pros...</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>genistein, placebo, therapeutic conventional s...</td>\n",
       "      <td>Given orally, Given orally, Radical prostatect...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>Number of Circulating Prostate Cells (CPCs) in...</td>\n",
       "      <td>Prostatic Neoplasms</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>5</td>\n",
       "      <td>TRB Chemedica International SA</td>\n",
       "      <td>INDUSTRY</td>\n",
       "      <td>SPONSOR</td>\n",
       "      <td>Efficacy and Safety of BUFY01 Versus SVS20 in ...</td>\n",
       "      <td>Efficacy and Safety of BUFY01 Versus SVS20 in ...</td>\n",
       "      <td>NOT_YET_RECRUITING</td>\n",
       "      <td>2024-03</td>\n",
       "      <td>ADULT OLDER_ADULT</td>\n",
       "      <td>Dry Eye Disease</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>BUFY01 eye drops in single-dose containers, SV...</td>\n",
       "      <td>1 to 2 drops in each eye, as often as needed, ...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Signs</td>\n",
       "      <td>Dry Eye Syndromes Keratoconjunctivitis Sicca E...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>6</td>\n",
       "      <td>Mansoura University</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>PRINCIPAL_INVESTIGATOR</td>\n",
       "      <td>Caudal Dexmedetomidine Analgesia in Pediatrics .</td>\n",
       "      <td>The Analgesic Effectiveness and Safety of Upgr...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>2019-01-01</td>\n",
       "      <td>CHILD</td>\n",
       "      <td>164 Boys for Hypospadias Surgery Under General...</td>\n",
       "      <td>SUPPORTIVE_CARE</td>\n",
       "      <td>Caudal dexamedatomidine analgesia</td>\n",
       "      <td>Technique performance (Caudal block): classica...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Time to (1st analgesic request objective pain ...</td>\n",
       "      <td>Hypospadias</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>7</td>\n",
       "      <td>Institute of Hematology &amp; Blood Diseases Hospi...</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>SPONSOR</td>\n",
       "      <td>A Study of PEG-rhG-CSF and rhG-CSF Used for Ap...</td>\n",
       "      <td>A Randomized,Open-label Dose-discovery Study o...</td>\n",
       "      <td>RECRUITING</td>\n",
       "      <td>2022-06-05</td>\n",
       "      <td>ADULT OLDER_ADULT</td>\n",
       "      <td>Severe Aplastic Anemia</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>PEG-rhG-CSF</td>\n",
       "      <td>PEG-rhG-CSF group A(q7d):6mg d1,8,subcutaneous...</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>total number of effective (ANC&gt;0.5Ã—109/L) days</td>\n",
       "      <td>Anemia Anemia, Aplastic</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>8</td>\n",
       "      <td>National Institutes of Health Clinical Center ...</td>\n",
       "      <td>NIH</td>\n",
       "      <td>SPONSOR</td>\n",
       "      <td>Screening Behavior in Adults With Hereditary H...</td>\n",
       "      <td>Illness Perceptions and the Health Belief Mode...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>2008-05-21</td>\n",
       "      <td>ADULT OLDER_ADULT</td>\n",
       "      <td>Osler-Rendu-Weber Disease, Osler-Rendu Disease...</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>OBSERVATIONAL</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>Unknown</td>\n",
       "      <td>Telangiectasis Telangiectasia, Hereditary Hemo...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>9</td>\n",
       "      <td>Cascade Pharmaceuticals, Inc</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>SPONSOR</td>\n",
       "      <td>A Study to Assess the Safety, Tolerability, Ph...</td>\n",
       "      <td>A Phase II, Randomized, Double-blind, Placebo-...</td>\n",
       "      <td>COMPLETED</td>\n",
       "      <td>2023-02-10</td>\n",
       "      <td>ADULT OLDER_ADULT</td>\n",
       "      <td>Nonalcoholic Steatohepatitis (NASH)</td>\n",
       "      <td>TREATMENT</td>\n",
       "      <td>CS0159 (Linafexor)</td>\n",
       "      <td>Oral QD</td>\n",
       "      <td>INTERVENTIONAL</td>\n",
       "      <td>PHASE2</td>\n",
       "      <td>MRI-PDFF Adverse events</td>\n",
       "      <td>Fatty Liver Non-alcoholic Fatty Liver Disease</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Unnamed: 0                             Organization Full Name  \\\n",
       "0           0                          Montefiore Medical Center   \n",
       "1           1                 Seoul National University Hospital   \n",
       "2           2                             Federico II University   \n",
       "3           3  Sidney Kimmel Comprehensive Cancer Center at J...   \n",
       "4           4                            Northwestern University   \n",
       "5           5                     TRB Chemedica International SA   \n",
       "6           6                                Mansoura University   \n",
       "7           7  Institute of Hematology & Blood Diseases Hospi...   \n",
       "8           8  National Institutes of Health Clinical Center ...   \n",
       "9           9                       Cascade Pharmaceuticals, Inc   \n",
       "\n",
       "  Organization Class       Responsible Party  \\\n",
       "0              OTHER                 SPONSOR   \n",
       "1              OTHER                 Unknown   \n",
       "2              OTHER  PRINCIPAL_INVESTIGATOR   \n",
       "3              OTHER                 SPONSOR   \n",
       "4              OTHER                 SPONSOR   \n",
       "5           INDUSTRY                 SPONSOR   \n",
       "6              OTHER  PRINCIPAL_INVESTIGATOR   \n",
       "7              OTHER                 SPONSOR   \n",
       "8                NIH                 SPONSOR   \n",
       "9              OTHER                 SPONSOR   \n",
       "\n",
       "                                         Brief Title  \\\n",
       "0  Kinesiotape for Edema After Bilateral Total Kn...   \n",
       "1  An Open-labeled Trial of Ramipril in Patients ...   \n",
       "2         OCTA in Epivascular Glia After Dex Implant   \n",
       "3  Preoperative Immune Checkpoint Inhibitor for P...   \n",
       "4  Genistein in Treating Patients With Prostate C...   \n",
       "5  Efficacy and Safety of BUFY01 Versus SVS20 in ...   \n",
       "6   Caudal Dexmedetomidine Analgesia in Pediatrics .   \n",
       "7  A Study of PEG-rhG-CSF and rhG-CSF Used for Ap...   \n",
       "8  Screening Behavior in Adults With Hereditary H...   \n",
       "9  A Study to Assess the Safety, Tolerability, Ph...   \n",
       "\n",
       "                                          Full Title      Overall Status  \\\n",
       "0  Effect of Kinesiotaping on Edema Management, P...           COMPLETED   \n",
       "1  An Open-labeled Trial of Ramipril in Patients ...           COMPLETED   \n",
       "2  Evaluation of Changes in Epivascular Glia Befo...           COMPLETED   \n",
       "3  Preoperative Immune Checkpoint Inhibitor Thera...           COMPLETED   \n",
       "4  Phase 2 Trial of Genistein in Men With Circula...          TERMINATED   \n",
       "5  Efficacy and Safety of BUFY01 Versus SVS20 in ...  NOT_YET_RECRUITING   \n",
       "6  The Analgesic Effectiveness and Safety of Upgr...           COMPLETED   \n",
       "7  A Randomized,Open-label Dose-discovery Study o...          RECRUITING   \n",
       "8  Illness Perceptions and the Health Belief Mode...           COMPLETED   \n",
       "9  A Phase II, Randomized, Double-blind, Placebo-...           COMPLETED   \n",
       "\n",
       "   Start Date       Standard Age  \\\n",
       "0  2021-10-18  ADULT OLDER_ADULT   \n",
       "1     2004-10  ADULT OLDER_ADULT   \n",
       "2  2021-01-01  ADULT OLDER_ADULT   \n",
       "3  2019-07-08  ADULT OLDER_ADULT   \n",
       "4  2011-02-03  ADULT OLDER_ADULT   \n",
       "5     2024-03  ADULT OLDER_ADULT   \n",
       "6  2019-01-01              CHILD   \n",
       "7  2022-06-05  ADULT OLDER_ADULT   \n",
       "8  2008-05-21  ADULT OLDER_ADULT   \n",
       "9  2023-02-10  ADULT OLDER_ADULT   \n",
       "\n",
       "                                          Conditions  Primary Purpose  \\\n",
       "0  Arthroplasty Complications, Arthroplasty, Repl...        TREATMENT   \n",
       "1                         Migraine With Hypertension        TREATMENT   \n",
       "2                               Diabetic Retinopathy          Unknown   \n",
       "3  Head and Neck Squamous Cell Carcinoma, Head an...        TREATMENT   \n",
       "4  Adenocarcinoma of the Prostate, Recurrent Pros...        TREATMENT   \n",
       "5                                    Dry Eye Disease        TREATMENT   \n",
       "6  164 Boys for Hypospadias Surgery Under General...  SUPPORTIVE_CARE   \n",
       "7                             Severe Aplastic Anemia        TREATMENT   \n",
       "8  Osler-Rendu-Weber Disease, Osler-Rendu Disease...          Unknown   \n",
       "9                Nonalcoholic Steatohepatitis (NASH)        TREATMENT   \n",
       "\n",
       "                                       Interventions  \\\n",
       "0                   Kinesio(R)Tape for edema control   \n",
       "1                                           Ramipril   \n",
       "2                 Dexamethasone intravitreal implant   \n",
       "3             Nivolumab 480mg and surgical resection   \n",
       "4  genistein, placebo, therapeutic conventional s...   \n",
       "5  BUFY01 eye drops in single-dose containers, SV...   \n",
       "6                  Caudal dexamedatomidine analgesia   \n",
       "7                                        PEG-rhG-CSF   \n",
       "8                                            Unknown   \n",
       "9                                 CS0159 (Linafexor)   \n",
       "\n",
       "                            Intervention Description      Study Type   Phases  \\\n",
       "0  Kinesio(R)Tape is an elastic, cotton tape with...  INTERVENTIONAL      NaN   \n",
       "1                         ramipril 2.5mg twice a day  INTERVENTIONAL   PHASE2   \n",
       "2                 Dexamethasone intravitreal implant   OBSERVATIONAL  Unknown   \n",
       "3  One dose of Nivolumab 480mg given four weeks p...  INTERVENTIONAL   PHASE2   \n",
       "4  Given orally, Given orally, Radical prostatect...  INTERVENTIONAL   PHASE2   \n",
       "5  1 to 2 drops in each eye, as often as needed, ...  INTERVENTIONAL      NaN   \n",
       "6  Technique performance (Caudal block): classica...  INTERVENTIONAL      NaN   \n",
       "7  PEG-rhG-CSF group A(q7d):6mg d1,8,subcutaneous...  INTERVENTIONAL      NaN   \n",
       "8                                            Unknown   OBSERVATIONAL  Unknown   \n",
       "9                                            Oral QD  INTERVENTIONAL   PHASE2   \n",
       "\n",
       "                                     Outcome Measure  \\\n",
       "0  Change from baseline and during 1-2-day time i...   \n",
       "1                                 headache frequency   \n",
       "2  Changes in epivascular glia after Dexamethason...   \n",
       "3  Safety as measured by number of participants w...   \n",
       "4  Number of Circulating Prostate Cells (CPCs) in...   \n",
       "5                                              Signs   \n",
       "6  Time to (1st analgesic request objective pain ...   \n",
       "7     total number of effective (ANC>0.5Ã—109/L) days   \n",
       "8                                            Unknown   \n",
       "9                            MRI-PDFF Adverse events   \n",
       "\n",
       "                            Medical Subject Headings  \n",
       "0                                              Edema  \n",
       "1                    Migraine Disorders Hypertension  \n",
       "2                               Diabetic Retinopathy  \n",
       "3  Carcinoma Carcinoma, Squamous Cell Head and Ne...  \n",
       "4                                Prostatic Neoplasms  \n",
       "5  Dry Eye Syndromes Keratoconjunctivitis Sicca E...  \n",
       "6                                        Hypospadias  \n",
       "7                            Anemia Anemia, Aplastic  \n",
       "8  Telangiectasis Telangiectasia, Hereditary Hemo...  \n",
       "9      Fatty Liver Non-alcoholic Fatty Liver Disease  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "print(\"_\" * 60)\n",
    "print(\"Sample data\")\n",
    "display(df.head(10))"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1cf866d8",
   "metadata": {},
   "source": [
    "## Key Insights: Categorical Variable Detection\n",
    "\n",
    "Identify likely categorical columns using a heuristic approach:\n",
    "- **Dynamic Threshold**: Uses the maximum of an absolute cutoff (20) and a percentage-based threshold (1% of total rows)\n",
    "- This adaptive approach works better for datasets of varying sizes\n",
    "- Columns with unique values below the threshold are likely categorical and candidates for separate lookup tables\n",
    "\n",
    "**Note**: This helped identify categorical vs continuous variables during initial exploration.\n",
    "```"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "id": "d755612a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "____________________________________________________________\n",
      "Key Insights:\n",
      "Column: Organization Class\n",
      "  - Number of uniques: 9\n",
      "  - Sample uniques: ['OTHER', 'INDUSTRY', 'NIH', 'OTHER_GOV', 'NETWORK', 'FED', 'INDIV', 'UNKNOWN', 'Unknown']\n",
      "\n",
      "Column: Responsible Party\n",
      "  - Number of uniques: 4\n",
      "  - Sample uniques: ['SPONSOR', 'Unknown', 'PRINCIPAL_INVESTIGATOR', 'SPONSOR_INVESTIGATOR']\n",
      "\n",
      "Column: Overall Status\n",
      "  - Number of uniques: 14\n",
      "  - Sample uniques: ['COMPLETED', 'TERMINATED', 'NOT_YET_RECRUITING', 'RECRUITING', 'ACTIVE_NOT_RECRUITING', 'UNKNOWN', 'WITHDRAWN', 'SUSPENDED', 'ENROLLING_BY_INVITATION', 'APPROVED_FOR_MARKETING', 'WITHHELD', 'NO_LONGER_AVAILABLE', 'AVAILABLE', 'TEMPORARILY_NOT_AVAILABLE']\n",
      "\n",
      "Column: Standard Age\n",
      "  - Number of uniques: 6\n",
      "  - Sample uniques: ['ADULT OLDER_ADULT', 'CHILD', 'ADULT', 'CHILD ADULT', 'CHILD ADULT OLDER_ADULT', 'OLDER_ADULT']\n",
      "\n",
      "Column: Primary Purpose\n",
      "  - Number of uniques: 11\n",
      "  - Sample uniques: ['TREATMENT', 'Unknown', 'SUPPORTIVE_CARE', 'BASIC_SCIENCE', 'HEALTH_SERVICES_RESEARCH', 'PREVENTION', 'DIAGNOSTIC', 'OTHER', 'DEVICE_FEASIBILITY', 'SCREENING', 'ECT']\n",
      "\n",
      "Column: Study Type\n",
      "  - Number of uniques: 4\n",
      "  - Sample uniques: ['INTERVENTIONAL', 'OBSERVATIONAL', 'EXPANDED_ACCESS', 'Unknown']\n",
      "\n",
      "Column: Phases\n",
      "  - Number of uniques: 9\n",
      "  - Sample uniques: ['PHASE2', 'Unknown', 'PHASE3', 'PHASE1', 'PHASE4', 'PHASE2, PHASE3', 'PHASE1, PHASE2', 'EARLY_PHASE1', 'No phases listed']\n",
      "\n"
     ]
    }
   ],
   "source": [
    "print(\"_\" * 60)\n",
    "print(\"Key Insights:\")\n",
    "\n",
    "absolute_cutoff = 20   # FIXME: I don't like this being hardcoded, but works for now\n",
    "percent_cutoff = 0.01  # 1% of rows, this is probably too high for large datasets\n",
    "n_rows = df.shape[0]\n",
    "dynamic_cutoff = max(absolute_cutoff, int(n_rows * percent_cutoff))\n",
    "\n",
    "for col in df.columns:\n",
    "    unique_vals = df[col].nunique(dropna=True)\n",
    "    if unique_vals <= dynamic_cutoff:\n",
    "        uniques_sample = df[col].dropna().unique()[:50]\n",
    "        print(f\"Column: {col}\")\n",
    "        print(f\"  - Number of uniques: {unique_vals}\")\n",
    "        print(f\"  - Sample uniques: {list(uniques_sample)}\\n\")\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
